News

Sparta Biopharma, Inc., a privately-held company, developing osteobiologics for sports medicine announces the availability of BioEnthesis, the first-of-its-kind allograft that has both…
Read More...

NeuroRx, Inc. and TFF Pharmaceuticals, Inc. are announcing that the companies have entered into a feasibility and material transfer agreement (Feasibility Agreement). Under the…
Read More...

Novartis announced the Phase III CANOPY-2 study evaluating canakinumab (ACZ885), an inhibitor of interleukin-1beta (IL-1β), in combination with the chemotherapy agent docetaxel, did not…
Read More...

Valo Therapeutics Limited (Valo Tx), the developer of novel and adaptable immunotherapy platforms for cancer and infectious diseases, announced the completion of a successful…
Read More...

VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announce the initiation of enrollment of its…
Read More...

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Maverick Therapeutics, Inc. a private biopharmaceutical company pioneering conditionally active…
Read More...

Melior Pharmaceuticals (Melior) announced that it has received clearance of its Investigational New Drug (IND) application for the clinical development of its novel, first-in-class lyn…
Read More...

Eli Lilly and Company and Biolojic Design Ltd. a biotechnology company that computationally designs functional antibodies, announced a research collaboration and license agreement that…
Read More...

Exelixis, Inc. and WuXi Biologics announced the companies have entered into an exclusive license agreement to support the continued expansion of Exelixis’ oncology biologics pipeline.…
Read More...

Roche announced that the company is voluntarily withdrawing the US indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics, LP announced preliminary results from Ridgeback’s Phase 2a randomized, double-blind,…
Read More...

Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced it has enrolled…
Read More...

Eli Lilly and Company announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for…
Read More...

EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and…
Read More...

ConserV Bioscience Limited a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA…
Read More...

Eisai Co., Ltd. announced that it has decided to assent to and support a project led by CA Medlynks Kenya, Ltd. (Headquarters: Nairobi), a subsidiary of the healthcare startup company…
Read More...

Amgen and Five Prime Therapeutics a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, announced an agreement under which Amgen…
Read More...

ALX Oncology Holdings Inc. a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, and Tallac Therapeutics, Inc. (“Tallac”), a privately…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic…
Read More...

The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA (lorlatinib), expanding the indication to include…
Read More...